Florence Dalenc

Focus on an infrequently used quantity in the context of competing risks: The conditional probability function

Bastien Cabarrou, Florence Dalenc, Eve Leconte, 2018, Comput. Biol. Medicine.

Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer – the INNODIAG study

Florence Dalenc, Thomas Filleron, Jean-Marie François, 2015, BMC Medical Genomics.

Symbolic Data Analysis to Defy Low Signal-to-Noise Ratio in Microarray Data for Breast Cancer Prognosis

Joseph Aguilar-Martin, Florence Dalenc, Marie-Véronique Le Lann, 2013, J. Comput. Biol..

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER).

Thomas Bachelot, Florence Dalenc, Thomas Filleron, 2014, The Lancet. Oncology.

Increased expression of a COOH‐truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells

Florence Dalenc, Gilles Favre, E. Cohen-Jonathan, 2002, International journal of cancer.

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

Thomas Bachelot, Florence Dalenc, Fabrice André, 2013, Clinical Cancer Research.

Genomic characterization of metastatic breast cancers

Yahia Adnani, Thomas Bachelot, Florence Dalenc, 2019, Nature.

Formation of the eIF4F translation-initiation complex determines sensitivity to anticancer drugs targeting the EGFR and HER2 receptors.

Florence Dalenc, Thomas Filleron, Magali Lacroix-Triki, 2011, Cancer research.